ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 56 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $134,051 | +33.5% | 89,367 | +41.5% | 0.00% | – |
| Q2 2023 | $100,409 | +50.3% | 63,150 | -32.2% | 0.00% | – |
| Q1 2023 | $66,826 | +3561.7% | 93,150 | +2857.1% | 0.00% | – |
| Q4 2022 | $1,825 | -8.8% | 3,150 | +57.5% | 0.00% | – |
| Q3 2022 | $2,000 | 0.0% | 2,000 | 0.0% | 0.00% | – |
| Q2 2022 | $2,000 | -33.3% | 2,000 | 0.0% | 0.00% | – |
| Q1 2022 | $3,000 | -25.0% | 2,000 | 0.0% | 0.00% | – |
| Q4 2021 | $4,000 | 0.0% | 2,000 | 0.0% | 0.00% | – |
| Q3 2021 | $4,000 | -50.0% | 2,000 | -16.7% | 0.00% | – |
| Q2 2021 | $8,000 | -66.7% | 2,400 | 0.0% | 0.00% | – |
| Q1 2021 | $24,000 | -7.7% | 2,400 | 0.0% | 0.00% | – |
| Q4 2020 | $26,000 | +4.0% | 2,400 | 0.0% | 0.00% | – |
| Q3 2020 | $25,000 | -50.0% | 2,400 | 0.0% | 0.00% | – |
| Q2 2020 | $50,000 | +108.3% | 2,400 | 0.0% | 0.00% | – |
| Q1 2020 | $24,000 | – | 2,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sonic Fund II, L.P. | 6,552,068 | $14,218,000 | 8.03% |
| Versant Venture Management, LLC | 5,068,233 | $10,998,000 | 4.55% |
| K2 PRINCIPAL FUND, L.P. | 1,653,874 | $3,589,000 | 0.29% |
| RTW INVESTMENTS, LP | 7,483,757 | $16,240,000 | 0.24% |
| Avoro Capital Advisors LLC | 6,950,000 | $15,082,000 | 0.24% |
| Artal Group S.A. | 3,000,000 | $6,510,000 | 0.15% |
| ALGERT GLOBAL LLC | 231,490 | $502,000 | 0.07% |
| Virtus ETF Advisers LLC | 57,768 | $125,000 | 0.06% |
| Pinz Capital Management, LP | 53,600 | $116,000 | 0.05% |
| TWIN FOCUS CAPITAL PARTNERS, LLC | 100,000 | $217,000 | 0.05% |